YBX1 and cancer: The involvement of YB-1 in the progression and resistance to stress and chemotherapy (Kang et al., 2013; Yang et al., 2010; El-Naggar et al., 2019), notably after its translocation in the nucleus in certain cancers (Bargou et al., 1997), has also been documented.